Horm Metab Res 2025; 57(01): 55-66
DOI: 10.1055/a-2458-7088
Original Article: Endocrine Care

Retracted Article: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related Genes

Autor*innen

  • Ziliang Shi

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
  • Zi Sang

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
  • Junmeng Xiao

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
  • Jianbin Hou

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
  • Mingfei Geng

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
Preview Container


Publikationsverlauf

Eingereicht: 24. Mai 2024

Angenommen nach Revision: 23. Oktober 2024

Artikel online veröffentlicht:
22. November 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany